Philip Wagenheim - Jan 15, 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
Jan 15, 2023
Transactions value $
$35,000
Form type
4
Date filed
1/17/2023, 05:30 AM
Previous filing
Jun 21, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Award $35K +8.75K +2.2% $4.00 406K Jan 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock were issued to the Reporting Person pursuant to the Issuer's 2020 Equity Compensation Plan in lieu of the non-employee director board and committee cash retainers of $35,000 in the aggregate owed to the Reporting Person for service on the board of directors in 2022.